Peri; Krishna G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Peri; Krishna G..The latest application filed is for "pegylated bioactive peptides and uses thereof".

Company Profile

0.13.13

Peri; Krishna G. - Montreal CA
Peri; Krishna G. - Ville Saint-Laurent CA
Peri; Krishna G. - St-Laurent CA
Peri, Krishna G. - Saint-Laurent CA
Peri, Krishna G. - Quebec CA
Peri, Krishna G. - Ville St-Laurent CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pegylated bioactive peptides and uses thereof Grant 10,918,730 - Peri February 16, 2	2021-02-16
Pegylated Bioactive Peptides And Uses Thereof App 20190209699 - PERI; Krishna G.	2019-07-11
Pegylated bioactive peptides and uses thereof Grant 9,988,428 - Peri June 5, 2	2018-06-05
Pegylated Bioactive Peptides And Uses Thereof App 20170296628 - PERI; KRISHNA G.	2017-10-19
Peptide compounds derived from melanotransferrin and uses thereof Grant 9,334,314 - Beliveau , et al. May 10, 2	2016-05-10
Peptide Compounds Derived From Melanotransferrin And Uses Thereof App 20150133385 - Beliveau; Richard ; et al.	2015-05-14
Bifunctional hormone having alpha-MSH activity and natriuretic peptide activity and uses thereof Grant 8,822,413 - Peri , et al. September 2, 2	2014-09-02
Growth hormone releasing factor (GRF) analogs and uses thereof Grant 8,361,964 - Peri , et al. January 29, 2	2013-01-29
Growth Hormone Releasing Factor (grf) Analogs And Uses Thereof App 20120270784 - Peri; Krishna G. ; et al.	2012-10-25
Bifunctional Hormone And Uses Thereof App 20090011997 - Peri; Krishna G. ; et al.	2009-01-08
Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis Grant 7,442,763 - Peri , et al. October 28, 2	2008-10-28
Antagonistic peptides of prostaglandin E2 receptor subtype EP4 Grant 7,414,029 - Peri , et al. August 19, 2	2008-08-19
Methods And Compounds For Prevention And Treatment Of Elevated Intraocular Pressure And Related Conditions App 20060292613 - Peri; Krishna G. ; et al.	2006-12-28
Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions Grant 7,094,761 - Peri , et al. August 22, 2	2006-08-22
Peptide antagonists of prostaglandin F2.alpha. receptor Grant 6,984,719 - Chemtob , et al. January 10, 2	2006-01-10
Antagonistic peptides of prostaglandin E2 receptor subtype EP4 App 20050164949 - Peri, Krishna G. ; et al.	2005-07-28
Compounds that modulate the glucagon response and uses thereof App 20050124550 - Peri, Krishna G.	2005-06-09
Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions App 20050059604 - Peri, Krishna G. ; et al.	2005-03-17
Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions Grant 6,864,239 - Peri , et al. March 8, 2	2005-03-08
Antagonistic peptides of prostaglandin E2 receptor subtype EP4 App 20040023853 - Peri, Krishna G. ; et al.	2004-02-05
PTH derivatives resistant to skin proteases App 20040023882 - Peri, Krishna G. ; et al.	2004-02-05
Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions App 20030212001 - Peri, Krishna G. ; et al.	2003-11-13
Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis App 20030017988 - Peri, Krishna G. ; et al.	2003-01-23
Antagonists of G-protein-coupled receptor Grant 5,955,575 - Peri , et al. September 21, 1	1999-09-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.